Black Patients With Lymphomatoid Papulosis
Lymphomatoid papulosis (LyP) is a CD30+ T-cell lymphoproliferative disorder (LPD) presenting as a recurrent eruption of papules and nodules which resolve spontaneously. CD30+ LPD prevalence in African American (AA)/Black patients is lower compared to White patients. CD30+ LPD has been recently reported to have worse outcomes in AA patients compared to White patients.
A retrospective chart revie …
Lymphomatoid papulosis (LyP) is a CD30+ T-cell lymphoproliferative disorder (LPD) presenting as a recurrent eruption of papules and nodules which resolve spontaneously. CD30+ LPD prevalence in African American (AA)/Black patients is lower compared to White patients. CD30+ LPD has been recently reported to have worse outcomes in AA patients compared to White patients.
A retrospective chart revie … Continue reading "Black Patients With Lymphomatoid Papulosis"
“All disease starts in the gut.” This saying may sound like a new fad, but in fact, this is quoted from Hippocrates himself (470-36 BCE) who proposed this--- not ten years ago, a hundred years ago, but thousands of years ago! Praised as one of the most influential figures in medicine and healing, Hippocrates upheld the theory of autointoxication, which claimed that by-products of incompl … 
The fusion of technology and medicine has led to the advent of advanced wound healing techniques that may be adapted to the management of surgical defects. Shortened duration of healing and ease-of-use are two potential benefits under investigation. Here, Matthew J. Lin MD, Danielle P. Dubin BA, Aaron S. Farberg MD, Hooman Khorasani MD, David A. Kriegel MD describe a 65-year-old male with a nasal … 
Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients. In this installment of our Therapeutic Cheat Sheet series, we’ll cover everything you need to know to start and monitor your patients on IL-17 blocking therapies.
[caption id="attachment_8301" align="alignleft" width="612"] Click image to en … 
Here are the issue highlights for the October issue of JDD!
Characterizing how AD patients are currently treated may build a reference for future clinical research in Prescribing Patterns for Atopic Dermatitis in the United States.
A Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old explores early intervention in infants and you … 